Loading organizations...
§ Private Profile · Decatur, GA, USA
Medical device company developing EarliPoint, an FDA-cleared device for autism spectrum disorder (ASD) diagnosis in toddlers.
Based in Decatur, Georgia, EarliTec Diagnostics develops EarliPoint, an FDA-cleared medical device utilizing artificial intelligence and eye-tracking technology to help clinicians diagnose autism spectrum disorder in toddlers aged 16 to 30 months. The system analyzes gaze patterns during a 12-minute video assessment of social interactions, delivering objective diagnostic data to healthcare providers and payors as a faster alternative to traditional multi-hour evaluations. The company currently operates 12 active devices across 8 clinical centers in six states across the United States. EarliTec Diagnostics has raised 41 million dollars in total venture capital funding, including a recent 21.5 million dollar Series B round backed by Nexus NeuroTech Ventures, Venture Investors, and Bernard Marcus. Co-founded in 2019 by Ami Klin, the digital health enterprise is now led by Chief Executive Officer Jamie Pagliaro to expand commercialization and research.
EarliTec Diagnostics has raised $41.0M across 2 funding rounds.
EarliTec Diagnostics has raised $41.0M in total across 2 funding rounds.
EarliTec Diagnostics has raised $41.0M in total across 2 funding rounds.
EarliTec Diagnostics's investors include William J. Marks, Jr., MD, MS, James Adox, Bernie Marcus, Bernard Marcus, Georgia Research Alliance.
EarliTec Diagnostics has raised $41.0M across 2 funding rounds. Most recently, it raised $21.5M Series B in April 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 6, 2024 | $21.5M Series B | William J. Marks, Jr., MD, MS, James Adox | — | Announced |
| Feb 18, 2022 | $19.5M Series A | Bernie Marcus, Bernard Marcus | Georgia Research Alliance | Announced |